Kates Klinik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 10.7% 6.9% 18.9% 12.5%  
Credit score (0-100)  0 23 34 6 18  
Credit rating  N/A BB BBB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 273 660 261 264  
EBITDA  0.0 22.0 193 -260 64.6  
EBIT  0.0 17.9 180 -266 51.2  
Pre-tax profit (PTP)  0.0 16.8 176.3 -271.9 48.3  
Net earnings  0.0 12.7 136.8 -212.8 37.6  
Pre-tax profit without non-rec. items  0.0 16.8 176 -272 48.3  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 25.3 103 57.1 43.7  
Shareholders equity total  0.0 52.7 190 -23.3 14.3  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 204 568 160 187  

Net Debt  0.0 -99.5 -297 -35.7 -89.4  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 273 660 261 264  
Gross profit growth  0.0% 0.0% 142.0% -60.5% 1.4%  
Employees  0 1 2 2 1  
Employee growth %  0.0% 0.0% 100.0% -10.0% -50.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 204 568 160 187  
Balance sheet change%  0.0% 0.0% 177.9% -71.8% 16.7%  
Added value  0.0 22.0 193.4 -252.1 64.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 21 64 -51 -27  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 -1.0 1.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 6.6% 27.2% -101.9% 19.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 8.7% 46.5% -70.7% 27.7%  
ROI %  0.0% 32.8% 144.4% -273.6% 716.8%  
ROE %  0.0% 24.1% 112.9% -121.7% 43.1%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 25.8% 33.4% -12.7% 7.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -451.1% -153.3% 13.7% -138.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 1.2 1.2 0.6 0.8  
Current Ratio  0.0 1.2 1.2 0.6 0.8  
Cash and cash equivalent  0.0 99.5 296.5 35.7 89.4  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 29.2 91.7 -80.4 -29.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 22 97 -140 72  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 22 97 -145 72  
EBIT / employee  0 18 90 -148 57  
Net earnings / employee  0 13 68 -118 42